Kevin Beja
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.
Journal: Journal of the National Cancer Institute
Published: March 30, 2023
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Journal: Nature
Published: November 13, 2021
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 03, 2021
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 09, 2020
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 18, 2020
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.
Journal: European urology
Published: January 20, 2020
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 17, 2019
Genetic and Molecular Analysis of Essential Genes in Centromeric Heterochromatin of the Left Arm of Chromosome 3 in Drosophila melanogaster.
Journal: G3 (Bethesda, Md.)
Published: April 06, 2019
Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer.
Journal: JCO precision oncology
Published: March 22, 2019
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Journal: European urology
Published: September 21, 2018
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.
Journal: Clinical genitourinary cancer
Published: May 28, 2018
Last Updated: 09/26/2026